Joel Greenblatt's EXAS Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 74,464 shares of Exact Sciences Corporation (EXAS) worth $7.56 M, representing 0.03% of the portfolio. First purchased in 2016-Q2, this long-term strategic position has been held for 39 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2017, adding 154,834 shares. Largest reduction occurred in Q4 2017, reducing 121,882 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +63,034 | Add 551.48% | 74,464 | $101.56 |
| Q3 2025 | -97,510 | Reduce 89.51% | 11,430 | $54.71 |
| Q2 2025 | +32,361 | Add 42.26% | 108,940 | $53.14 |
| Q1 2025 | -73,541 | Reduce 48.99% | 76,579 | $43.29 |
| Q4 2024 | -12,302 | Reduce 7.57% | 150,120 | $56.19 |
| Q3 2024 | +30,873 | Add 23.47% | 162,422 | $68.12 |
| Q2 2024 | +56,440 | Add 75.14% | 131,549 | $42.25 |
| Q1 2024 | +8,650 | Add 13.02% | 75,109 | $69.06 |
| Q4 2023 | -27,822 | Reduce 29.51% | 66,459 | $73.98 |
| Q3 2023 | +4,347 | Add 4.83% | 94,281 | $68.22 |
| Q2 2023 | +11,100 | Add 14.08% | 89,934 | $93.90 |
| Q1 2023 | -2,086 | Reduce 2.58% | 78,834 | $67.81 |
| Q4 2022 | +46,059 | Add 132.12% | 80,920 | $49.51 |
| Q3 2022 | +34,861 | New Buy | 34,861 | $32.50 |
| Q2 2022 | -6,092 | Sold Out | 0 | $0.00 |
| Q1 2022 | -2,398 | Reduce 28.24% | 6,092 | $69.93 |
| Q4 2021 | +1,815 | Add 27.19% | 8,490 | $77.86 |
| Q3 2021 | +1,940 | Add 40.97% | 6,675 | $95.43 |
| Q2 2021 | +33 | Add 0.70% | 4,735 | $124.39 |
| Q1 2021 | -1,134 | Reduce 19.43% | 4,702 | $131.86 |
| Q4 2020 | -1,027 | Reduce 14.96% | 5,836 | $132.45 |
| Q3 2020 | -1,250 | Reduce 15.41% | 6,863 | $102.00 |
| Q2 2020 | +9 | Add 0.11% | 8,113 | $86.90 |
| Q1 2020 | +2,099 | Add 34.95% | 8,104 | $58.00 |
| Q4 2019 | +6,005 | New Buy | 6,005 | $92.42 |
| Q3 2019 | -3,591 | Sold Out | 0 | $0.00 |
| Q2 2019 | -41,400 | Reduce 92.02% | 3,591 | $118.07 |
| Q1 2019 | +944 | Add 2.14% | 44,991 | $86.62 |
| Q4 2018 | +221 | Add 0.50% | 44,047 | $63.09 |
| Q3 2018 | -48,316 | Reduce 52.44% | 43,826 | $78.93 |
| Q2 2018 | -36,472 | Reduce 28.36% | 92,142 | $59.79 |
| Q1 2018 | -86,423 | Reduce 40.19% | 128,614 | $40.33 |
| Q4 2017 | -121,882 | Reduce 36.18% | 215,037 | $52.54 |
| Q3 2017 | +154,834 | Add 85.03% | 336,919 | $47.12 |
| Q2 2017 | +126,037 | Add 224.87% | 182,085 | $35.37 |
| Q1 2017 | +56,048 | New Buy | 56,048 | $23.62 |
| Q4 2016 | -53,252 | Sold Out | 0 | $0.00 |
| Q3 2016 | +35,583 | Add 201.39% | 53,252 | $18.57 |
| Q2 2016 | +17,669 | New Buy | 17,669 | $12.22 |
Joel Greenblatt's Exact Sciences Corporation Investment FAQs
Joel Greenblatt first purchased Exact Sciences Corporation (EXAS) in Q2 2016, acquiring 17,669 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Exact Sciences Corporation (EXAS) for 39 quarters since Q2 2016.
Joel Greenblatt's largest addition to Exact Sciences Corporation (EXAS) was in Q3 2017, adding 336,919 shares worth $15.88 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 74,464 shares of Exact Sciences Corporation (EXAS), valued at approximately $7.56 M.
As of the Q4 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.03% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Exact Sciences Corporation (EXAS) was 336,919 shares, as reported at the end of Q3 2017.